Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Inflamm Bowel Dis. 2010 Aug;16(8):1421–1430. doi: 10.1002/ibd.21246

TABLE 1.

Outcome of Oral Methotrexate Therapy (12.5 mg orally/week) in a Prospective, Randomized Trial (Ref. 16)

Placebo
n=37
Methotrexate
n=30
Remission (n) 48.6% (18) 46.7% (14)
Time to remission (months) 3.4 ± 1.7 4.1 ± 1.9
Relapse after achieving
 remission (n)
44.4% (8) 46.7% (9)
Drop outs (n) 24.3% (9) 6.7% (2)
Treatment failure 5.4% (2) 10% (3)
Withdrawal because of side effect 2.7% (1) 6.7% (2)